ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,339Medicare Part D Prescriptions Filled, Including Refills

Rank: 73 out of 1278

$612K Total Retail Price of All Prescriptions

Rank: 69 out of 1278

494 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 494 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 494 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 6,520 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 463 314 1 1
METOPROLOL TARTRATE 371 309 2 9
LEVOTHYROXINE SODIUM 317 208 3 2
OXYCODONE HCL 285 70 S2 4 27
HYDROCODONE-ACETAMINOPHEN 272 156 S3 5 7
SIMVASTATIN 257 193 6 3
AMLODIPINE BESYLATE 234 175 7 5
OMEPRAZOLE 217 169 8 6
MORPHINE SULFATE ER 216 68 S2 9 42
FUROSEMIDE 211 149 10 10
GABAPENTIN 199 75 11 12
RANITIDINE HCL 193 119 12 20
METFORMIN HCL 191 156 13 4
PRAVASTATIN SODIUM 174 112 14 14
POTASSIUM CHLORIDE 134 97 15 21
ATENOLOL 129 85 16 11
DOXAZOSIN MESYLATE 123 70 17 69
WARFARIN SODIUM 119 94 18 17
TRAMADOL HCL 112 89 19 25
ALLOPURINOL 112 79 19 36
LOSARTAN POTASSIUM 108 72 21 19
VERAPAMIL ER 107 73 22 84
SERTRALINE HCL 105 95 23 28
AZITHROMYCIN 102 71 24 37
SULFAMETHOXAZOLE-TRIMETHOPRIM 100 65 25 90
CARISOPRODOL 99 11 R 26 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 69 27 30
TAMSULOSIN HCL 96 69 28 32
FLUOXETINE HCL 95 35 29 41
TRAZODONE HCL 95 44 29 38
TRIAMTERENE-HCTZ 94 63 31 43
NAMENDA 93 89 32 77
ESTRADIOL 80 26 R 33 71
METHADONE HCL 79 12 S2 34 112
GLYBURIDE 78 57 R 35 40
PANTOPRAZOLE SODIUM 78 67 35 34
PROAIR HFA 78 45 35 26
LANTUS 78 54 35 33
OXYCONTIN 75 0 S2 39 89
DONEPEZIL HCL 74 74 40 48
PREMARIN 69 37 R 41 119
RISPERIDONE 69 51 41 92
AMITRIPTYLINE HCL 68 22 R 43 55
FENOFIBRATE 68 45 43 47
CYMBALTA 67 34 45 67
INSULIN SYRINGE 66 31 46 50
CEPHALEXIN 65 40 47 73
GEMFIBROZIL 64 25 48 54
METOPROLOL SUCCINATE 62 47 49 23
NAPROXEN 62 39 49 70
CARVEDILOL 59 47 51 39
PAROXETINE HCL 59 22 51 56
ADVAIR DISKUS 56 35 53 49
CLOPIDOGREL 52 45 54 45
SPIRONOLACTONE 50 41 55 78
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.